Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04726 |
| Species: | Homo sapiens |
| Position : | chr11:111250000-111350000 |
| Year: | 2022 |
| Title: | Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | diffuse large B-cell lymphoma |
| PMID: | 34162177 |
| MONDO: | MONDO:0018905 |
| Tissue: | lymph node |
| Tissue Ontology ID: | UBERON:0000029 |
| Cell Source: | BE10 |
| CVCL ID: | CVCL_8804 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq; RNA-seq |
| Low Throughput Method: | ChIP-RT-qPCR, qRT-PCR |
| Target gene : | POU2AF1 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03923 | chr11:111284123-111290712 | bone marrow | B cell | diffuse large B-cell lymphoma |